Life Sciences

Our Global Life Sciences sector can help you navigate forward and achieve sustainable success in the new health-outcomes-driven ecosystem.

Aging populations and chronic disease are putting pressure on health resources around the world just as scientific progress, augmented intelligence and digital data are transforming the traditional health care models. This is causing a power shift with new entrants (often not driven by profit) disrupting the incumbents.

 

Staying competitive and providing the personalized experience that patients demand require life sciences organizations to find new ways of working. Partnering with others to share data, medicine and resources while anticipating trends and regulatory changes will help ensure sustainability in the increasingly evidence-based, outcomes-focused sector.

 

We help companies across the biotechnology, pharmaceutical and medical technology fields harness this disruption by forming the right alliances, better allocating resources and building trust with customers.

Our Latest thinking

Why licensing deals are a powerful source of growth

Innovation is key in Life Sciences. In response to challenges, pharmaceutical companies increasingly turn to external innovation, leveraging licensing deals. Learn more.

03 Oct 2024 Dr. Markus von Minden +1

AI's role in pharma manufacturing and supply chain

In this episode, listeners will hear how AI is playing an increasingly important role in pharma manufacturing. Learn more.

13 Jun 2024 24m 13s

The Unstoppables: Success stories of the world’s most inspiring entrepreneurs

The latest EY entrepreneurship documentary, “The Unstoppables 3,” features inspiring professional and personal entrepreneur success stories. Read more.

09 Apr 2024 Stasia Mitchell

What pharma supply chain transformation means for tax

Businesses looking to create visibility and resilience in their supply chains must loop in tax and transfer pricing teams early in the process. Learn more.

15 Mar 2024 Ana Maria Romero

Life sciences dealmaking in a time of change

Life sciences companies are returning to dealmaking amid cost and revenue pressures – how will they find the right deals to secure value? Learn more.

08 Jan 2024 Subin Baral

Global Voices in Health Care

The EY Global Voices in Health Care Study finds health systems must embrace sustainable care delivery models to address workforce challenges. Learn more.

16 Oct 2023 Jenny Parker +1

Supply chain visibility strategic priority for pharma

With digitally driven end-to-end supply chain visibility, pharma companies will be better prepared for the next major supply chain disruption. Learn more.

04 Oct 2023 Derron Stark +1

How digital is changing the tax strategy for MedTech

As MedTech companies make substantial investments in digital technology, there are important tax implications that should be addressed. Learn more.

18 Aug 2023 Ana Maria Romero +2

Case study: Takeda’s finance transformation with EY teams

In this case study, learn how leading pharmaceutical company Takeda is creating value for patients through finance innovation and process excellence.

14 Aug 2023 Frederik Schmachtenberg +2

How Takeda harnessed the power of the metaverse for positive human impact

Learn how Takeda harnessed the power of the metaverse for positive human impact.

27 Jun 2023 Edwina Fitzmaurice +4

How Takeda harnessed the power of the metaverse for positive human impact

Learn how Takeda harnessed the power of the metaverse for positive human impact.

27 Jun 2023 Edwina Fitzmaurice +4

How early diagnosis can transform health care

Mirxes’ Dr. Zhou Lihan shares his purpose and passion for a more proactive approach to medicine. Learn more.

14 Jun 2023 EY Global

Innovation can utilize data for value-based care

Organizations have the tools to deliver a better personalized health experience, but the ecosystem needs to collaborate to build this future. Learn more.

20 Mar 2023 Pamela Spence

Life sciences businesses transform tax and finance

Life sciences organizations operate in a complex industry – one that looks set to become more challenging, including from a tax perspective. Learn more.

07 Mar 2023 EY Global

Why life sciences tax departments need to act now on sustainability

Life sciences organizations should consider tax liabilities and compliance obligations resulting from myriad new sustainability taxes. Learn more.

11 Jan 2023 Rick Fonte +2

Tailor-made cancer treatments to be delivered at scale

Collaboration can save lives. EY wavespace brought together industry leaders in building a cell and gene therapy platform to fight disease.

27 Oct 2022

How innovative infostructure can power the purpose of integrated care systems

Sharing organized and complete data to generate insights for better health outcomes is the driving force behind joined-up care in integrated care systems (ICSs).

18 Sept 2022 Aloha McBride +1

How the challenge of regulating AI in healthcare is escalating

Artificial intelligence is forcing healthcare regulators to play catch-up and reimagine the regulation rule book.

How do you build future supply chains to best serve patient needs?

In the wake of global disruptions, EY research aims to map out the future for supply chain transformation in the pharmaceutical industry. Read more.

18 Jul 2022 Derron Stark +2

How CDMOs are leading innovation for pharmaceutical partners

Discover how CDMO M&A trends show CDMOs are becoming emerging technology leaders for pharmaceutical partners.

14 Jul 2022 Dr. Isabelle Heiber

    Life Sciences 4.0

    When the human body is the biggest data platform, who will capture value?



    Contact us
    Like what you’ve seen? Get in touch to learn more.
    You are visiting EY aus-nzl (en)
    aus-nzl en